{\rtf1\ansi\deff0\deftab360

{\fonttbl
{\f0\fswiss\fcharset0 Arial}
{\f1\froman\fcharset0 Times New Roman}
{\f2\fswiss\fcharset0 Verdana}
{\f3\froman\fcharset2 Symbol}
}

{\colortbl;
\red0\green0\blue0;
}

{\info
{\author Biblio 7.x}{\operator }{\title Biblio RTF Export}}

\f1\fs24
\paperw11907\paperh16839
\pgncont\pgndec\pgnstarts1\pgnrestart
Carpenter D. Visions of the Republic: Petitions, Associations and Elections in Early America.; In Press.\par \par Carpenter D, Tobbell D. ?Bioequivalence: The Regulatory Career of a Pharmaceutical Concept? . Bulletin of the History of Medicine. Submitted.\par \par Carpenter D, Grimmer J, Lomazoff E. ?Approval Regulation and Endogenous Consumer Confidence: Theory and an Analogies to Licensing, Safety and Financial Regulation? . Regulation and Governance . 2010;4(4).\par \par Carpenter D, Moffitt S, Moore C, Rynbrandt R, Ting M, Yohai I, Zucker EJ. ?Early-Entrant Protection in Approval Regulation: Theory and Evidence from FDA Drug Review?. Journal of Law  Economics and Organization  . 2010;26(2).\par \par  ?Institutional Strangulation: Bureaucratic Politics and Financial Reform in the Obama Administration? . Perspective on Politics. 2010;8(3):825-46.\par \par  Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA. Princeton: Princeton University Press; 2010.\par \par Carpenter D. ?Reputation  Information and Confidence ? The Political Economy of Pharmaceutical Regulation? . Public Choice and Public Law . 2010.\par \par Carpenter D, Keyhani S, Anderson G, Hebert P, Wang S. ?U.S. Pharmaceutical Innovation in an International Context? . American Journal of Public Health [Internet]. 2010;(6):1075-1080.\par \par Carpenter D. ?Confidence Games: How Does Regulation Constitute Markets??. In: Balleisen E, Moss D Towards a New Theory of Regulation. New York : Cambridge University Press; 2009.\par \par Carpenter D. ?Regulation? . In: Kazin M The Princeton Encyclopedia of Political History . ; 2009.\par \par Carpenter D, Zucker EJ, Avorn J. ?Drug Review Deadlines and Subsequent Safety Problems?. New England Journal of Medicine  . 2008;358(13):1354-61.\par \par Carpenter D, Volden C, Ting M. ?A Formal Model of Learning and Policy Diffusion? . American Political Science Review . 2008;102 (3):319-32.\par \par Carpenter D. ?The Leaning Tower of PISA: Fundamental Problems in Ignorance-Based Theories of State Autonomy?  . Critical Review . 2007.\par \par Carpenter D, Sin G. ?Policy Tragedy and the Emergence of Regulation: The Food  Drug and Cosmetic Act of 1938? . Studies in American Political Development . 2007;21(2):149-180.\par \par Carpenter D, Ting M. ?Regulatory Errors with Endogenous Agendas?. American Journal of Political Science . 2007;51(4):835-853.\par \par Carpenter D, Moore CD. ?Robust Action and the Strategic Use of Ambiguity in a Bureaucratic Cohort: FDA Scientists and the Investigational New Drug Regulations of 1963? . In: Glassman M, Skowronek S Formative Acts: American Politics in the Making  . University of Pennsylvania Press  ; 2007.\par \par Carpenter D. ?Reputation  Gatekeeping and the Politics of Post-marketing Drug Regulation?. Virtual Mentor [American Medical Association]  [Internet]. 2006;8:403-406.\par \par Carpenter D, Armstrong E, Hojnacki M. ?Whose Deaths Matter? Mortality  Identity  and Attention to Disease in the Mass Media? . Journal of Health Politics  Policy and Law  . 2006;31(4):729-772.\par \par Carpenter D. ?The Evolution of National Bureaucracy in the United States? . In: Aberbach JD, Peterson M, of Branch TIAD: TE New York: Oxford University Press  ; 2005. p. 41-71.\par \par Carpenter D. ?A Modest Proposal for Financing Postmarketing Drug Safety Studies by Augmenting FDA User Fees? . Health Affairs ? Web Exclusive . 2005;W5 (469).\par \par Carpenter D, Ting M. ?The Political Logic of Regulatory Error? . Nature Reviews ? Drug Discovery . 2005;4(10):819-823.\par \par Carpenter D, Fendrick MA. ?Accelerating Approval Times for New Drugs in the U.S?. The Regulatory Affairs Journal ? Pharma. 2004;15(6):411-417.\par \par Carpenter D, Fendrick MA, Chernew M, Smith D. ?Approval Times for New Drugs: Does the Source of Funding for FDA Staff Matter?? . Health Affairs ? Web Exclusive. 2004;W3- 618-624.\par \par Carpenter D, Esterling K, Lazer D. ?Friends  Brokers and Transitivity: Who Talks with Whom in Washington Lobbying?? . Journal of Politics . 2004;66(1):224-246.\par \par Carpenter D. ?Gatekeeping and the FDA?s Role in Human Subjects Protection? . Virtual Mentor [American Medical Association] . 2004;6.\par \par Carpenter D. ?The Political Economy of FDA Drug Approval: Processing  Politics and Implications for Policy?  . Health Affairs. 2004;23(1):52-63.\par \par Carpenter D, Lewis D. ?Political Learning from Rare Events: Poisson Inference  Fiscal Constraints  and the Lifetime of Bureaus? . Political Analysis. 2004;12(3):201-232.\par \par Carpenter D. ?Protection without Capture: Product Approval by a Politically Responsive Learning Regulator?. American Political Science Review  . 2004;98(4):613-631.\par \par Carpenter D. ?Staff Resources Speed FDA Drug Review? . Journal of Health Policy  Politics and Law. 2004;29(3):431-442.\par \par Carpenter D, Whittington K. ?Executive Power in American Institutional Development? . Perspectives on Politics. 2003;1(3):495-513.\par \par Carpenter D, Cram P, Inadomi J, Vijay S, Fendrick MA. ?The Impact of a Celebrity Promotional Campaign on the Use of Colon Cancer Screening: The Case of Katie Couric? . Archives of Internal Medicine  . 2003;63:1601-1605.\par \par Carpenter D, Lazer D, Esterling K. ?Information and Contact-Making in Policy Networks: A Model with Evidence from the U.S. Health Policy Domain? . Rationality and Society  . 2003;15(4):411-440.\par \par Carpenter D.  ?The Multiple and Material Legacies of Stephen Skowronek? . Social Science History . 2003;27(3):465- 474.\par \par Carpenter D. ?Why Do Bureaucrats Delay? Lessons from a Stochastic Optimal Stopping Model of Product Approval? forthcoming. In: Meier K, Krause G Scientific Approaches to Bureaucratic Politics. Ann Arbor: University of Michigan Press; 2003.\par \par Carpenter D. ?Why Do Bureaucrats Delay? Lessons from a Stochastic Optimal Stopping Model of Product Approval? forthcoming   . In: Meier K, Krause G ; 2003.\par \par Carpenter D. ?Groups  the Media  Agency Waiting Costs  and FDA Drug Approval?. American Journal of Political Science. 2002;46(2):490-505.\par \par Carpenter D. The Forging of Bureaucratic Autonomy: Networks, Reputations and Policy Innovation in Executive Agencies, 1862- 1928.; 2001.\par \par Carpenter D. ?The Political Foundations of Bureaucratic Autonomy: A Reply to Kernell?  . Studies in American Political Development  . 2001;15(1):113-122.\par \par Carpenter D. Robert Wood Johnson Foundation Scholars in Health Policy Working Paper #21. In: 2000 Midwest Political Science Association. ; 2000.\par \par Carpenter D. ?State Building through Reputation Building: Policy Innovation and Coalitions of Esteem at the Post Office  1883-1912? . Studies in American Political Development  . 2000;14(2):121-55.\par \par Carpenter D. ?State Building through Reputation Building: Policy Innovation and Coalitions of Esteem at the Post Office  1883-1912?   . Studies in American Political Development . 2000;14(2):121-55.\par \par Carpenter D. ?Stochastic Prediction and Estimation of Nonlinear Political Durations: An Application to the Lifetime of Bureaus?   . In: Political Complexity. Ann Arbor: University of Michigan Press  ; 2000.\par \par Carpenter D. ?What is the Marginal Value of Analytic Narratives?? . Social Science History . 2000;24(4):653-67.\par \par Carpenter D. ?From Patronage to Policy: The Centralization Campaign in Iowa Post Offices  1880-1910? . Annals of Iowa . 1999.\par \par Carpenter D. ?Centralization and the Corporate Metaphor in Executive Departments  1880-1928?   . Studies in American Political Development . 1998;12(1):106-147.\par \par Carpenter D, Esterling K, Lazer D. ?The Strength of Weak Ties in Lobbying: Evidence from Health Care Politics in the United States? . Journal of Theoretical Politics   . 1998;10(4):417-44.\par \par Carpenter D. ?Adaptive Signal Processing  Hierarchy  and Budgetary Control in Federal Regulation?. American Political Science Review  . 1996;90(2):283-302.\par \par }